Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -396.52% is 75% above its 1-year average of -1588.15%, near the high end of its 1-year range (-5595.93%–0.00%).
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -671.97%.
NET PROFIT MARGIN
-396.52%
NET PROFIT MARGIN AVG TTM
N/A
NET PROFIT MARGIN AVG 3Y
N/A
NET PROFIT MARGIN AVG 5Y
N/A
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-152407.69%
vs the sector median at left
Atrium Therapeutics, Inc.
Market Cap
$138.04M
Net Profit Margin
-396.52%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$137.61M
Net Profit Margin
-4.03%
TTM Avg
-12.22%
3Y Avg
-25.92%
5Y Avg
-21.35%
Market Cap
$139.08M
Net Profit Margin
-153.61%
TTM Avg
-101.12%
3Y Avg
-50.56%
5Y Avg
-33.71%
Market Cap
$135.85M
Net Profit Margin
27.54%
TTM Avg
-18.99%
3Y Avg
-63.93%
5Y Avg
-73.34%
Market Cap
$140.67M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-3984.32%
5Y Avg
-3047.80%
Market Cap
$134.21M
Net Profit Margin
-10.40%
TTM Avg
-6.28%
3Y Avg
-16.07%
5Y Avg
-47.85%
Market Cap
$141.49M
Net Profit Margin
-395.25%
TTM Avg
-276.53%
3Y Avg
-199.61%
5Y Avg
-174.03%
Market Cap
$133.68M
Net Profit Margin
-7.79%
TTM Avg
-6.13%
3Y Avg
-5.81%
5Y Avg
-0.54%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Atrium Therapeutics, Inc. (RNA) | $138.04M | -396.52% | N/A | N/A | N/A |
| KORU Medical Systems, Inc. (KRMD)vs › | $137.61M | -4.03% | -12.22% | -25.92% | -21.35% |
| Alpha Cognition Inc (ACOG)vs › | $139.08M | -153.61% | -101.12% | -50.56% | -33.71% |
| Freenome, Inc. (FRNM)vs › | $135.82M | N/A | N/A | N/A | N/A |
| Organigram Global Inc. (OGI)vs › | $135.85M | 27.54% | -18.99% | -63.93% | -73.34% |
| Immuneering Corporation (IMRX)vs › | $140.67M | 0.00% | 0.00% | -3984.32% | -3047.80% |
| LifeMD, Inc. (LFMD)vs › | $134.21M | -10.40% | -6.28% | -16.07% | -47.85% |
| Sutro Biopharma, Inc. (STRO)vs › | $141.49M | -395.25% | -276.53% | -199.61% | -174.03% |
| AirSculpt Technologies, Inc. (AIRS)vs › | $133.68M | -7.79% | -6.13% | -5.81% | -0.54% |
| Health Catalyst, Inc. (HCAT)vs › | $132.64M | -90.61% | -39.94% | -42.38% | -48.96% |
Operating Margin
-410.2%
Net Profit Margin
-396.5%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -671.97% |
| 2026-03-31 | -84.71% |
| 2025-12-31 | -5595.93% |
| 2025-09-30 | 0.00% |
